These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors. Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis. Çoban-Karataş M; Özkale Y; Altan-Yaycıoğlu R; Sızmaz S; Pelit A; Metindoğan S; Cantürk-Uğurbaş S; Aydın-Akova Y Turk J Pediatr; 2014; 56(4):410-7. PubMed ID: 25818961 [TBL] [Abstract][Full Text] [Related]
38. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis. Hingorani M; Calder VL; Buckley RJ; Lightman S Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598 [TBL] [Abstract][Full Text] [Related]
39. An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis. Esposito S; Fior G; Mori A; Osnaghi S; Ghiglioni D Paediatr Drugs; 2016 Oct; 18(5):347-55. PubMed ID: 27461427 [TBL] [Abstract][Full Text] [Related]
40. Vitamin D levels in children affected by vernal keratoconjunctivitis. Zicari AM; Cafarotti A; Occasi F; Lollobrigida V; Nebbioso M; Pecorella I; De Castro G; Spalice A; Loffredo L; Villa MP; Duse M Curr Med Res Opin; 2017 Feb; 33(2):269-274. PubMed ID: 27786545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]